Prince Pharmaceutical Co., Ltd. (TPEX:6935)
Taiwan · Delayed Price · Currency is TWD 30.70
+0.10 (0.33%)
At close: Jan 22, 2026
Prince Pharmaceutical Company Description
Prince Pharmaceutical Co., Ltd. manufactures and sells vitamin B1 active pharmaceutical ingredients (APIs) in Taiwan, Japan, Korea, and internationally.
The company also offers health food and medicines; vitamin c tablets, vitamin b complex tablets, natto and rhodiola extract capsules, probiotic sachets, and plant extract capsules; and API products comprising felbinac, aldioxa, tulobuterol, ufenamate, bisbentiamine, thiamine disulfide, potassium guaiacolsulfonate, potassium cresolsulfonate, fusultiamine hydrochloride, and fursultiamine.
Prince Pharmaceutical Co., Ltd. was founded in 1962 and is headquartered in Yunlin County, Taiwan.
Prince Pharmaceutical Co., Ltd.
| Country | Taiwan |
| Founded | 1962 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 210 |
| CEO | Da Li |
Contact Details
Address: No.168, Keyun S. Road Yunlin County, 632 Taiwan | |
| Phone | 886 5 632 6910 |
| Website | prince-pharm.com.tw |
Stock Details
| Ticker Symbol | 6935 |
| Exchange | Taipei Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0006935000 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Da Li | GM and Chairman |
| Cuiwei Chen | Accounting Supervisor |